Vermont Pharmaceutical Marketer Price Disclosure Main Article

Vermont Pharmaceutical Marketer Price Disclosure

Information for Prescribers of Prescription Drugs


Those affected by Vermont's Prescription Marketing Law can refer to the documents below to compare prices of our products with similar generic choices in the same therapeutic class.

  • Lists provided in the links do not imply that the products are interchangeable or have the same efficacy or safety. Please refer to each product's FDA-approved label for further information.
  • Prices listed are Average Wholesale Prices (AWP) as established by a third-party publisher. Prices paid by consumers may be higher or lower.
  • Prices reflect price per dosage, per course of treatment, or the cost of effectiveness of all products listed. For simplicity, only the smallest package sizes available for each product are included.

Information for Vermont Prescribers of Prescription Drugs

(prasugrel) tablets
See full prescribing information including boxed warning regarding bleeding risk
Effient Vermont prescribers information

(cevimeline HCI)
See full prescribing information
Evoxac Vermont prescribers information

(morphine sulfate) extended-release tablets CII
See full prescribing information including boxed warnings and Medication Guide
Morphabond™ER Perscribing Information

(naloxegol oxalate)
See full prescribing information
Movantik Vermont prescribers information

See full prescribing information including boxed WARNINGS and Medication Guide
Savaysa Vermont prescribers information

(colesevelam HCL)
See full prescribing information
Welchol Vermont prescribers information

See full prescribing information
Zelboraf Vermont prescribers information

Pharmaceutical Marketer Price Disclosure More Sotries

Learn More

Patient Assistance Programs

A commitment to ensuring that our medicines are available to those who need them most is just as ...

read more ...